RBP4 and COVID-19: An observational study examined that, compared to nonpatients, hospitalized COVID-19 patients had reduced VA plasma levels regardless of disease severity, and critically ill COVID-19 patients had reduced RBP4 plasma levels during their acute phase of illness [10].